SlideShare uma empresa Scribd logo
1 de 52
DRUGS AND THE KIDNEY

                 BY
      Dr: Mahmoud A. Kora
Ass.prof of Int. Medicine & Nephrology
          Menoufia University
                  2012
Who should be
interested in this topic
           ?
Every body should
       be

      ?why
Because of 2 reasons
       the first one

is that we are all prescribing
      drugs all the time
The second one is more
          important



Which is that every body
 usually has 2 kidneys
Many drugs can injure the kidneys,
but they cause renal injury via only
. a few common mechanisms

Many patients who develop renal
injury after drug exposure have
identifiable risk factors that could be
???. modified
Renal elimination of drugs
Drugs may be eliminated via the kidneys by
  two main mechanisms:
 Glomerular filtration: a passive process
  such drugs will be water-soluble.
 Activetubular secretion: drugs act as
 substrates for secretory processes that
 are designed to eliminate endogenous
 molecules. ???
When renal disease leads to a
 reduction in nephron, the kidney’s
 ability to eliminate drugs declines
 in proportion to the decline in
 glomerular filtration rate. As renal
 failure progresses, drugs filtered or
 secreted by the kidney can
 accumulate , potentially resulting
 in toxicity.
Renal injury can present as acute
 renal failure, Nephrotic syndrome,
 renal tubular dysfunction, or chronic
 renal failure
   Drug nephrotoxicity
Drugs can lead to renal damage in a
   number of different ways :
1. Alteration of renal blood flow
 NSAIDs:alteration in prostaglandin
   metabolism can lead to critical
   reduction in glumerular perfusion,
   interstitial nephritis can also result
   from NSAIDs
 ACE inhibitors and ARBs: ARF or
   renal impairment ????
Occurring in patients who are critically
  dependant upon RAA system.
 Cyclosporine A




2. Direct tubular toxicity
 Aminoglycosides :disturbance of renal
  function is seen in up to a third of patients
  receiving aminoglycosides.
 Cisplatin  : selectively toxic to proximal
  tubules by inhibiting nuclear DNA
  synthesis
 Amophotercin:
3.glumerulonephritis
 Gold :
      Is believed to induce an immune
  complex GN
 Penicillamine :
     It is dose related
4. Other nephrotoxic effects of drugs:
 Interstitial nephritis
 Retropertoneal fibrosis
 Drug induced SLE
 Nephrogenic DI
Drugs which accumulate and cause
 toxicity in patients with sever renal
 failure include:
1.Pencillins and cephalosporins high dose.
2.digoxin
3. Erythromycin
Nephrotoxic drugs may lead to an acute
  deterioration of renal function in patients
  with CRF and they can severely excerbates
  renal damage in ARF.
Absorption of some drugs may be altered in
  uremia as a consequence of
edema of the gastrointestinal tract coupled
  with uremic nausea ,vomiting or
  gastroparesis. Alteration in the distribution
  of drugs vary depending on the agents .
  Acidic drugs will have a higher free fraction
  in the plasma of uremic patients as a
  consequence of decrease protein binding.
How nephrotoxic are the
        NSAIDs ?
 PG  have relatively little effect on the
  normal kidney in the euvolemic person
 However in renal insufficiency or
  hypovolemic states PG are important in
  maintaining adequate glomerular flow and
  pressure by VD of renal arteries , ↑ Na loss
  and ↑ rennin release
nephrotoxic effects of NSAIDs
↑  Na retention and blood volume (CHF)
 Papillary necrosis
↑ K
 Acute allergic interstitial nephritis ass with
  fenoprofen
 ATN
 Interstitial nephritis with aspirin
  ,caffeine ???
Diabetic drugs and the kidney
Glucophage
Insulin
TZDs
Acarboses
DPP-IV  Inhibitors
sulphonylureas
Insulin in renal patients
Insulin resistance
Insulin catabolism
Liver diseases and
      the kidney
Which organ you should be more
 careful about?
HRS
Electrolyte disturbance
Renal impairment in HCV
Heart failure and the kidney

■ Diuretics

■ digitalis

■ B-blocker in HD patients
Radio-contrast     nephropathy
Mild renal dysfunction may complicate up to
 10% of angiographic procedures and
 IVUs. Radio-contrast nephropathy is
 manifest by non oliguric ARF, typically
 occurring 1-5 days after the procedure.
 Intra- renal vasoconstriction, mediated
 largely by endothelin, and tubular cell
 toxicity (with ATN) are important in the
 pathogenesis . The ARF is fully reversible.
Risk factors for radio- contrast nephropathy
 High contrast load
 Hypovolaemia
 Myeloma , Hyperuricaemia
 Age
 High iodine content of contrast
 Diabetes
 Hypercalcaemia
 Pre-existing CRF
KDIGO 2012
 Consider alternative imaging methods in patients at
  increased risk for CI-AKI. (Not Graded)

 Use  the lowest possible dose of contrast medium in
  patients at risk for CI-AKI. (Not Graded)

 We  recommend using either iso-osmolar or low-
  osmolar iodinated contrast media, rather than high-
  osmolar iodinated contrast media in patients at
  increased risk of CI-AKI. (1B)

 We  recommend i.v. volume expansion with either
  isotonic sodium chloride or sodium bicarbonate
  solutions, rather than no i.v. volume expansion, in
  patients at increased risk for CI-AKI. (1A)
 We  recommend not using oral fluids alone in patients
 at increased risk of CI-AKI. (1C)

 We suggest using oral NAC, together with i.v.
 isotonic crystalloids, in patients at increased risk of
 CI-AKI. (2D)

 Wesuggest not using theophylline to prevent CI-
 AKI. (2C)

 Werecommend not using fenoldopam to prevent CI-
 AKI. (1B)

 We suggest not using prophylactic intermittent
 hemodialysis (IHD) or hemofiltration (HF) for
 contrast-media removal in patients at increased risk
 for CI-AKI. (2C)
The  objective is to
obtain a therapeutic
drug concentration-
time profile that is
therapeutic and not
toxic.
GENERAL PRINCIPLES
Be vigilant. Adverse renal effects of drugs are
 largely silent in the early stages

. Identify patients at risk

.Take precautions

Manage the renal failure
When in doubt about the
cause of renal failure, hold
all potentially offending
drugs
A careful history and physical
 examination are always the first steps
 in clinical evaluation of patients with
 renal disease. Particularly important for
 this purpose is the history of previous
 drug allergy or toxicity and the use of
 concurrent medications.
Physical assessment should include
An estimate of the extracellular fluid volume.
Oh ??
Edema or ascites increases the distribution
 volume of many drugs, while dehydration
 contracts this volume. Evidence of impaired
 function of other excretory organs should
 be sought. Stigmata of liver disease are clue
 that the drug dose may need to be altered.
II. Measurement of renal function

the rate of elimination of drugs excreted by the
  kidneys is proportional to the glomerular
  filtration rate. The serum creatinine , creatinine
  clearance is needed to determine renal function
  before prescribing many drugs . The Cockcroft
  and Gault equation is useful for this purpose, as
  shown in the following formula:
CrCl (ml/min)= (140-age)x (BW in kg)(x0.85if female)
                        72x Scr(mg/dl)
The Scr reflects muscle mass as well as
 glomerular filtration rate. Scr
 measurement within the normal range
 are frequently used to establish normal
 renal function. This may cause serious
 over- dose and resultant toxic drugs
 accumulation in elderly or debilitated
 patients with decreased muscle mass.
?Do we have another option
Cystatin  –C is a good indicator of
 renal function specially in children
 and elderly patients
Estimated GFR is the best way to
 assess progression of kidney
 disease in chronic renal patients
Pretreatment hydration can reduce
 the nephrotoxic potential of many
 drugs.

So ,it is very simple steps by which
 you can avoid getting yourself and
 your patient in a big problem.
 What   are special concerns regarding the
  use of antimicrobial agents in patients with
  renal failure?
 The majority of antimicrobial agents are
  excreted at least partially by the kidney so
  that dose reductions often are apporpiate
  in patients with glumerular filtration rates
  less than 50% of normal. Gastrointestinal
  absorption      of      tetracycline    and
  ciprofloxacin may me decreased if
How should antibiotic doses be adjusted in patients
   with renal failure?
Several antibiotics need dosage modification in the
   presence of renal failure, most cephalosporins,
   many penicillin's and vancomycin. The
   adjustments can be made by :
1. maintaining the usual dose and varying the
   dosing interval,
2. maintaining the dosing interval and varying the
   dose,
3. or a combination of the two.
they are taken with phosphate-binding
  antacids. Decreased protein binding may
  contribute to increased neurotoxicity of
  betalactam antibiotics in patients with
  renal failure.
Nephrotoxicity of antimicrobial agents is a
  major concern in patients with impaired
  renal function and limited renal reserve.
  The majority offenders are the
  aminoglycosides and Amophotercin.
The catabolic effects of tetracycline may
 results in a rise in blood urea nitrogen and
 therefore its use should be avoided in
 patients with advanced renal insufficiency.
Many of the penicillins are prepared with
 sodium or pottasium. High doses of such
 agents may be problematiac in renal
 patients with volume overload of
 hyperkalemia.
Dosing of antimicrobial drugs in renal
  patients
 Antimicrobial and antiprotozoal drugs
Drug               Half-life       Dosage for severe renal failure
                   Normal/ESRD
                   (h)
Amoxycillin        0.09-2.3/5-20   Maximum 500 mgq 8h


Amoxycillin        Amoxycillin     Maximum 375 mg q12 h
Clavulanic acid PO 0.9-2.3/5-20
                   Clavulanic
                   acid1/3-4
ampicillin         0.8-1.5/7-20    250-500 mg q6h


Cefotaxime IV      1/15             1g loading dose then 50% standard
                                   dose
Drug                 Half-life   Dosage for severe renal failure
                                Normal/ESRD
                                    (h)

Ceftazidime IV        1.2/13-25               0.5-1 g q24h

Ceftriaxone IV        7-9/12-24               1-2 g q24h
Cefuroxime IV         1.2/17                  750 mg q12h

Cefuroxime PO         1.2/17                  Standard dose
Cephalexin            0.7/16                  250-500 mg q12h
Chloroquiine          7-14 days/5- 50 days    Treatment:50% standard
                                              dose
Ciprofloxacin IV/PO   3-6/6-9                 50% standard dose q12h
Calrithromycin        2.3-6.0/-               250 mg q12h

Cotrimoxazole         Sulphamethoxazole       PCP treatment:Standard dose
IV/PO                 10/20-50                q48h
Sulphamethoxazole/    Trimethoprime           PCP prophylaxis
Trimethoprime         9-13/20-49              25% Standard dose q48-72h

Erythromycin IV/PO    1.4/5-6                 50-75% Standard dose
                                              Max 1.5g in 24h
Drug                             Half-life           Dosage for severe renal failure
                                            Normal/ESRD
                                                (h)
Flucloxacillin                    0.8-1/3                         Max PO 500 mg q6hIV 1g q 6 h
Gentamicin IV                     1.8/20-60                       Titrate to levels

Impenem/ cilastin IV              Impenem ¼                       250 mg or 3.5 mg/kg q12 h
                                  Cilastin1/15-24
Meropenem IV                      1.1/6-8                         50% standard dose q24h

Penoxymethyl-pencillin            0.6/4.1                         Standard dose

Piperacillin IV                   0.8-1.8/3.3-5.1                 4 g q12 h

Piperacillin/dihydrochloride IV   Piperacillin 0.18-0.3/3.3-5.1   4.5 g q12 h
                                  Dihydrochloride 1/7
Quinine difydrochloride IV        9 healthy,18 malaria/           Treat,emt 5-10 mg/kg q24h
                                  unchanged
Trimethoprim                      9-13/20-49                      50% standard dose

Vancomycin IV                     6-8/200-250                     Titrate to levels
Dosing of common drugs in renal patients

 Allopurinol-GFR      30 ml/min use
  100mg,60ml/min use 200mg,90ml/min use
  300mg
 Corticosteroids-no need to change the dose
 NSAIDs :-most are metabolized in the
  liver , aspirin is a good choice in renal
  impairment,
   - In ESRD patients ,no need for dose
  adjustment
 In patients with low urine output avoid
  sulindac owing to renal stone formation.
 Reduce dose of ketoprofen
 Penicillamine ,avoid if GFR less than
  50ml/min
 Cyclosporine, no dose adjustment in renal
  insufficiency, however use of Cyclosporine
  can worsen renal insufficiency
 Gold , if GFR 50-75ml/min use 50% of
  usual dose ,if less than 50% avoid gold
 Methotrexate   ,take care from hematologic
  toxicity
 Tacrolimus (FK506,prograf)….Gout
 Sulfasalasine ,no change in dose.
 Mycophenylate mofetil (cellcept) ,mainly
  hepatic metabolism ,but if GFR less than 25
  ml/min reduce dose by 25%.
 Tramadol , give dose every 12 h instead of
  every 6h
 Narcotics, avoid using Darvon and
  Mepiridine, for others if GFR less than
  10ml/min cut 50% of the dose ,if GFR 10-
  50ml/min use 75% of the dose
You are what you repeatedly
 do; then excellence is not an
      art but just a habit

           Aristo
nk y ou
T ha

Mais conteúdo relacionado

Mais procurados

DRUGS AND TOXINS ASSOCIATED WITH KIDNEY
DRUGS AND TOXINS ASSOCIATED WITH KIDNEYDRUGS AND TOXINS ASSOCIATED WITH KIDNEY
DRUGS AND TOXINS ASSOCIATED WITH KIDNEYSSOUNDARI
 
Pharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerationsPharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerationsDr Htet
 
vitamins in chronic kidney disease and hemodialysis patients
 vitamins in chronic kidney disease and hemodialysis patients vitamins in chronic kidney disease and hemodialysis patients
vitamins in chronic kidney disease and hemodialysis patientsPediatric Nephrology
 
Drug induced kidney disease
Drug induced kidney diseaseDrug induced kidney disease
Drug induced kidney diseaseMuhammad Arsal
 
Drug use in hepatic and renal impairment
Drug use in hepatic and renal impairmentDrug use in hepatic and renal impairment
Drug use in hepatic and renal impairmentAkshil Mehta
 
Dose adjustment in renal disease
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal diseaseAreej Abu Hanieh
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury anoop k r
 
Crrt sudan 2017 dr. osama el shahat
Crrt sudan 2017  dr. osama el shahatCrrt sudan 2017  dr. osama el shahat
Crrt sudan 2017 dr. osama el shahatFarragBahbah
 
Molecular mechanism of drug induced nephrotoxicity
Molecular mechanism of drug induced nephrotoxicityMolecular mechanism of drug induced nephrotoxicity
Molecular mechanism of drug induced nephrotoxicitySuman Manandhar
 
Drug induced kidney disease (injury)
Drug induced kidney disease (injury)Drug induced kidney disease (injury)
Drug induced kidney disease (injury)Dr. Ankit Gaur
 
Use of diuretics in congestive heart failure. pptx
Use of diuretics in congestive heart failure. pptxUse of diuretics in congestive heart failure. pptx
Use of diuretics in congestive heart failure. pptxJimmy Potter
 
Acute complications of haemodialysis
Acute complications of haemodialysisAcute complications of haemodialysis
Acute complications of haemodialysisDr Narinder Sharma
 
Vasoactive peptides
Vasoactive peptidesVasoactive peptides
Vasoactive peptidesViraj Shinde
 
Dialyisis disequilibrium syndrome
Dialyisis disequilibrium syndromeDialyisis disequilibrium syndrome
Dialyisis disequilibrium syndromesaihari17
 
Disorders of Renal Function by Dr Kemi Dele
Disorders of Renal Function by Dr Kemi DeleDisorders of Renal Function by Dr Kemi Dele
Disorders of Renal Function by Dr Kemi DeleKemi Dele-Ijagbulu
 
Thiazide diuretics.pptx
Thiazide diuretics.pptxThiazide diuretics.pptx
Thiazide diuretics.pptxDoha Rasheedy
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapyDr Kumar
 

Mais procurados (20)

DRUGS AND TOXINS ASSOCIATED WITH KIDNEY
DRUGS AND TOXINS ASSOCIATED WITH KIDNEYDRUGS AND TOXINS ASSOCIATED WITH KIDNEY
DRUGS AND TOXINS ASSOCIATED WITH KIDNEY
 
Pharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerationsPharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerations
 
vitamins in chronic kidney disease and hemodialysis patients
 vitamins in chronic kidney disease and hemodialysis patients vitamins in chronic kidney disease and hemodialysis patients
vitamins in chronic kidney disease and hemodialysis patients
 
Drug induced kidney disease
Drug induced kidney diseaseDrug induced kidney disease
Drug induced kidney disease
 
Drug use in hepatic and renal impairment
Drug use in hepatic and renal impairmentDrug use in hepatic and renal impairment
Drug use in hepatic and renal impairment
 
Dose adjustment in renal disease
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal disease
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury
 
Crrt sudan 2017 dr. osama el shahat
Crrt sudan 2017  dr. osama el shahatCrrt sudan 2017  dr. osama el shahat
Crrt sudan 2017 dr. osama el shahat
 
Molecular mechanism of drug induced nephrotoxicity
Molecular mechanism of drug induced nephrotoxicityMolecular mechanism of drug induced nephrotoxicity
Molecular mechanism of drug induced nephrotoxicity
 
Drug induced kidney disease (injury)
Drug induced kidney disease (injury)Drug induced kidney disease (injury)
Drug induced kidney disease (injury)
 
Use of diuretics in congestive heart failure. pptx
Use of diuretics in congestive heart failure. pptxUse of diuretics in congestive heart failure. pptx
Use of diuretics in congestive heart failure. pptx
 
Acute complications of haemodialysis
Acute complications of haemodialysisAcute complications of haemodialysis
Acute complications of haemodialysis
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Vasoactive peptides
Vasoactive peptidesVasoactive peptides
Vasoactive peptides
 
Dialyisis disequilibrium syndrome
Dialyisis disequilibrium syndromeDialyisis disequilibrium syndrome
Dialyisis disequilibrium syndrome
 
Disorders of Renal Function by Dr Kemi Dele
Disorders of Renal Function by Dr Kemi DeleDisorders of Renal Function by Dr Kemi Dele
Disorders of Renal Function by Dr Kemi Dele
 
Thiazide diuretics.pptx
Thiazide diuretics.pptxThiazide diuretics.pptx
Thiazide diuretics.pptx
 
Diuretics
DiureticsDiuretics
Diuretics
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 

Destaque

Pharmacology Kidney Drugs
Pharmacology   Kidney DrugsPharmacology   Kidney Drugs
Pharmacology Kidney Drugspinoy nurze
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failurePallavi Kurra
 
The Pathophysiology Of Acute Renal Failure
The Pathophysiology Of Acute Renal FailureThe Pathophysiology Of Acute Renal Failure
The Pathophysiology Of Acute Renal FailureBayu_F_Wibowo
 
Acute and Chronic Renal Failure. Easy Slides.
Acute and Chronic Renal Failure. Easy Slides.Acute and Chronic Renal Failure. Easy Slides.
Acute and Chronic Renal Failure. Easy Slides.Anubhav Singh
 
chronic kidney disease.ppt
chronic kidney disease.pptchronic kidney disease.ppt
chronic kidney disease.pptshashank agrawal
 
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsDose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsKareem El-Fass BPharm,PharmD
 
Nephrotoxicity mechanism
Nephrotoxicity mechanismNephrotoxicity mechanism
Nephrotoxicity mechanismIrum Chohan
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failureJijo G John
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney DiseaseAndre Garcia
 
Ischemic and toxic renal injury and renal disease in pregnancy
Ischemic and toxic renal injury and renal disease in pregnancyIschemic and toxic renal injury and renal disease in pregnancy
Ischemic and toxic renal injury and renal disease in pregnancydrpallavip
 
IC netwerk scholingsavond presentatie slab zout 22apr14
IC netwerk scholingsavond presentatie slab zout 22apr14IC netwerk scholingsavond presentatie slab zout 22apr14
IC netwerk scholingsavond presentatie slab zout 22apr14Medisch Centrum Haaglanden
 

Destaque (20)

Drugs acting on the kidney lectures 1 and 2
Drugs acting on the kidney lectures 1 and 2Drugs acting on the kidney lectures 1 and 2
Drugs acting on the kidney lectures 1 and 2
 
Pharmacology Kidney Drugs
Pharmacology   Kidney DrugsPharmacology   Kidney Drugs
Pharmacology Kidney Drugs
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
 
The Pathophysiology Of Acute Renal Failure
The Pathophysiology Of Acute Renal FailureThe Pathophysiology Of Acute Renal Failure
The Pathophysiology Of Acute Renal Failure
 
Acute and chronic renal failure
Acute and chronic renal failureAcute and chronic renal failure
Acute and chronic renal failure
 
Nephrotoxicity eman 2013
Nephrotoxicity eman 2013Nephrotoxicity eman 2013
Nephrotoxicity eman 2013
 
Acute and Chronic Renal Failure. Easy Slides.
Acute and Chronic Renal Failure. Easy Slides.Acute and Chronic Renal Failure. Easy Slides.
Acute and Chronic Renal Failure. Easy Slides.
 
Chronic renal failure
Chronic renal failure Chronic renal failure
Chronic renal failure
 
chronic kidney disease.ppt
chronic kidney disease.pptchronic kidney disease.ppt
chronic kidney disease.ppt
 
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsDose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
 
Nephrotoxicity mechanism
Nephrotoxicity mechanismNephrotoxicity mechanism
Nephrotoxicity mechanism
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Diuretic drugs
Diuretic drugsDiuretic drugs
Diuretic drugs
 
Renal Failure
Renal FailureRenal Failure
Renal Failure
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Disease
 
Ischemic and toxic renal injury and renal disease in pregnancy
Ischemic and toxic renal injury and renal disease in pregnancyIschemic and toxic renal injury and renal disease in pregnancy
Ischemic and toxic renal injury and renal disease in pregnancy
 
Drug dosing
Drug dosingDrug dosing
Drug dosing
 
Bananen
BananenBananen
Bananen
 
IC netwerk scholingsavond presentatie slab zout 22apr14
IC netwerk scholingsavond presentatie slab zout 22apr14IC netwerk scholingsavond presentatie slab zout 22apr14
IC netwerk scholingsavond presentatie slab zout 22apr14
 

Semelhante a Kidney Health and Drug Interactions

Prof. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with akiProf. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with akiwessam1071
 
Eman anan- drugs -step- workshop-final 2
Eman anan- drugs -step- workshop-final 2Eman anan- drugs -step- workshop-final 2
Eman anan- drugs -step- workshop-final 2FAARRAG
 
Renal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdfRenal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdfOctavioGamez1
 
Renal impairment and anaesthesia
Renal impairment and anaesthesiaRenal impairment and anaesthesia
Renal impairment and anaesthesiaErrol Williamson
 
5th y dental special pk consideration in elderly
5th y dental special pk consideration in elderly5th y dental special pk consideration in elderly
5th y dental special pk consideration in elderlyKAU
 
anaesthestic implications in a case of chronic kidneydisease
anaesthestic implications in a case of chronic kidneydiseaseanaesthestic implications in a case of chronic kidneydisease
anaesthestic implications in a case of chronic kidneydiseaseShameek Datta
 
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptxANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptxSweetPotatoe1
 
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...shaistasumayya2
 
Drug induced renal failure By Shaista Sumayya
Drug induced renal failure By Shaista SumayyaDrug induced renal failure By Shaista Sumayya
Drug induced renal failure By Shaista SumayyaPARUL UNIVERSITY
 
Anesthesia for Patients with Renal Disease.pptx
Anesthesia for Patients with Renal Disease.pptxAnesthesia for Patients with Renal Disease.pptx
Anesthesia for Patients with Renal Disease.pptxTadesseFenta1
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.pptNekHang
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury AIIMS, New Delhi, India
 
Intensive care nephrology
Intensive care nephrologyIntensive care nephrology
Intensive care nephrologyFarragBahbah
 
ANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptxANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptxShaistaSumayya
 
Onconephrology shield the kidney while fighting cancer , dr ayman seddik
Onconephrology shield the kidney while fighting cancer , dr ayman seddikOnconephrology shield the kidney while fighting cancer , dr ayman seddik
Onconephrology shield the kidney while fighting cancer , dr ayman seddikAyman Seddik
 
Diet in renal diseases
Diet in renal diseasesDiet in renal diseases
Diet in renal diseasesO'Brian Reid
 
Acute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementAcute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementdrriyas03
 
Renal-_Nephrotoxic_Drugs.pdf
Renal-_Nephrotoxic_Drugs.pdfRenal-_Nephrotoxic_Drugs.pdf
Renal-_Nephrotoxic_Drugs.pdfSanjayaManiDixit
 

Semelhante a Kidney Health and Drug Interactions (20)

Prof. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with akiProf. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with aki
 
Eman anan- drugs -step- workshop-final 2
Eman anan- drugs -step- workshop-final 2Eman anan- drugs -step- workshop-final 2
Eman anan- drugs -step- workshop-final 2
 
Renal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdfRenal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdf
 
Renal impairment and anaesthesia
Renal impairment and anaesthesiaRenal impairment and anaesthesia
Renal impairment and anaesthesia
 
5th y dental special pk consideration in elderly
5th y dental special pk consideration in elderly5th y dental special pk consideration in elderly
5th y dental special pk consideration in elderly
 
anaesthestic implications in a case of chronic kidneydisease
anaesthestic implications in a case of chronic kidneydiseaseanaesthestic implications in a case of chronic kidneydisease
anaesthestic implications in a case of chronic kidneydisease
 
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptxANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
 
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
 
Drug induced renal failure By Shaista Sumayya
Drug induced renal failure By Shaista SumayyaDrug induced renal failure By Shaista Sumayya
Drug induced renal failure By Shaista Sumayya
 
Anesthesia for Patients with Renal Disease.pptx
Anesthesia for Patients with Renal Disease.pptxAnesthesia for Patients with Renal Disease.pptx
Anesthesia for Patients with Renal Disease.pptx
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.ppt
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.ppt
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury
 
Intensive care nephrology
Intensive care nephrologyIntensive care nephrology
Intensive care nephrology
 
Pharmacology part 4
Pharmacology part 4Pharmacology part 4
Pharmacology part 4
 
ANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptxANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptx
 
Onconephrology shield the kidney while fighting cancer , dr ayman seddik
Onconephrology shield the kidney while fighting cancer , dr ayman seddikOnconephrology shield the kidney while fighting cancer , dr ayman seddik
Onconephrology shield the kidney while fighting cancer , dr ayman seddik
 
Diet in renal diseases
Diet in renal diseasesDiet in renal diseases
Diet in renal diseases
 
Acute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementAcute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic management
 
Renal-_Nephrotoxic_Drugs.pdf
Renal-_Nephrotoxic_Drugs.pdfRenal-_Nephrotoxic_Drugs.pdf
Renal-_Nephrotoxic_Drugs.pdf
 

Mais de Mahmoud El-saharty (15)

Presentation
PresentationPresentation
Presentation
 
Drug prescription in hepatic patients
Drug prescription in hepatic patientsDrug prescription in hepatic patients
Drug prescription in hepatic patients
 
Drug prescription in hepatic patients
Drug prescription in hepatic patientsDrug prescription in hepatic patients
Drug prescription in hepatic patients
 
Acute renal failure in icu .....
Acute renal failure in icu .....Acute renal failure in icu .....
Acute renal failure in icu .....
 
Abdominal compartment syndrome[1]
Abdominal compartment syndrome[1]Abdominal compartment syndrome[1]
Abdominal compartment syndrome[1]
 
Syncope
SyncopeSyncope
Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Dobutamine stress echo
Dobutamine stress echoDobutamine stress echo
Dobutamine stress echo
 
Dobutamine stress echo
Dobutamine stress echoDobutamine stress echo
Dobutamine stress echo
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Acute gi b leed (revised) (p) copy
Acute gi b leed (revised) (p)   copyAcute gi b leed (revised) (p)   copy
Acute gi b leed (revised) (p) copy
 
Hcv, difficult gps (shebeen)
Hcv, difficult gps (shebeen)Hcv, difficult gps (shebeen)
Hcv, difficult gps (shebeen)
 
Mokhtar overview & acs-2012-final
Mokhtar overview & acs-2012-finalMokhtar overview & acs-2012-final
Mokhtar overview & acs-2012-final
 
Cor pulmonale
Cor pulmonaleCor pulmonale
Cor pulmonale
 
Statin intolerant patients
Statin intolerant patientsStatin intolerant patients
Statin intolerant patients
 

Último

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 

Último (20)

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 

Kidney Health and Drug Interactions

  • 1.
  • 2. DRUGS AND THE KIDNEY BY Dr: Mahmoud A. Kora Ass.prof of Int. Medicine & Nephrology Menoufia University 2012
  • 3. Who should be interested in this topic ?
  • 5. Because of 2 reasons the first one is that we are all prescribing drugs all the time
  • 6. The second one is more important Which is that every body usually has 2 kidneys
  • 7. Many drugs can injure the kidneys, but they cause renal injury via only . a few common mechanisms Many patients who develop renal injury after drug exposure have identifiable risk factors that could be ???. modified
  • 8. Renal elimination of drugs Drugs may be eliminated via the kidneys by two main mechanisms:  Glomerular filtration: a passive process such drugs will be water-soluble.  Activetubular secretion: drugs act as substrates for secretory processes that are designed to eliminate endogenous molecules. ???
  • 9. When renal disease leads to a reduction in nephron, the kidney’s ability to eliminate drugs declines in proportion to the decline in glomerular filtration rate. As renal failure progresses, drugs filtered or secreted by the kidney can accumulate , potentially resulting in toxicity.
  • 10. Renal injury can present as acute renal failure, Nephrotic syndrome, renal tubular dysfunction, or chronic renal failure
  • 11.
  • 12. Drug nephrotoxicity Drugs can lead to renal damage in a number of different ways : 1. Alteration of renal blood flow  NSAIDs:alteration in prostaglandin metabolism can lead to critical reduction in glumerular perfusion, interstitial nephritis can also result from NSAIDs  ACE inhibitors and ARBs: ARF or renal impairment ????
  • 13. Occurring in patients who are critically dependant upon RAA system.  Cyclosporine A 2. Direct tubular toxicity  Aminoglycosides :disturbance of renal function is seen in up to a third of patients receiving aminoglycosides.
  • 14.  Cisplatin : selectively toxic to proximal tubules by inhibiting nuclear DNA synthesis  Amophotercin: 3.glumerulonephritis  Gold : Is believed to induce an immune complex GN  Penicillamine : It is dose related
  • 15. 4. Other nephrotoxic effects of drugs:  Interstitial nephritis  Retropertoneal fibrosis  Drug induced SLE  Nephrogenic DI
  • 16.
  • 17. Drugs which accumulate and cause toxicity in patients with sever renal failure include: 1.Pencillins and cephalosporins high dose. 2.digoxin 3. Erythromycin Nephrotoxic drugs may lead to an acute deterioration of renal function in patients with CRF and they can severely excerbates renal damage in ARF.
  • 18. Absorption of some drugs may be altered in uremia as a consequence of edema of the gastrointestinal tract coupled with uremic nausea ,vomiting or gastroparesis. Alteration in the distribution of drugs vary depending on the agents . Acidic drugs will have a higher free fraction in the plasma of uremic patients as a consequence of decrease protein binding.
  • 19. How nephrotoxic are the NSAIDs ?  PG have relatively little effect on the normal kidney in the euvolemic person  However in renal insufficiency or hypovolemic states PG are important in maintaining adequate glomerular flow and pressure by VD of renal arteries , ↑ Na loss and ↑ rennin release
  • 20. nephrotoxic effects of NSAIDs ↑ Na retention and blood volume (CHF)  Papillary necrosis ↑ K  Acute allergic interstitial nephritis ass with fenoprofen  ATN  Interstitial nephritis with aspirin ,caffeine ???
  • 21. Diabetic drugs and the kidney Glucophage Insulin TZDs Acarboses DPP-IV Inhibitors sulphonylureas
  • 22. Insulin in renal patients Insulin resistance Insulin catabolism
  • 23. Liver diseases and the kidney Which organ you should be more careful about? HRS Electrolyte disturbance Renal impairment in HCV
  • 24. Heart failure and the kidney ■ Diuretics ■ digitalis ■ B-blocker in HD patients
  • 25. Radio-contrast nephropathy Mild renal dysfunction may complicate up to 10% of angiographic procedures and IVUs. Radio-contrast nephropathy is manifest by non oliguric ARF, typically occurring 1-5 days after the procedure. Intra- renal vasoconstriction, mediated largely by endothelin, and tubular cell toxicity (with ATN) are important in the pathogenesis . The ARF is fully reversible.
  • 26. Risk factors for radio- contrast nephropathy  High contrast load  Hypovolaemia  Myeloma , Hyperuricaemia  Age  High iodine content of contrast  Diabetes  Hypercalcaemia  Pre-existing CRF
  • 27.
  • 28. KDIGO 2012  Consider alternative imaging methods in patients at increased risk for CI-AKI. (Not Graded)  Use the lowest possible dose of contrast medium in patients at risk for CI-AKI. (Not Graded)  We recommend using either iso-osmolar or low- osmolar iodinated contrast media, rather than high- osmolar iodinated contrast media in patients at increased risk of CI-AKI. (1B)  We recommend i.v. volume expansion with either isotonic sodium chloride or sodium bicarbonate solutions, rather than no i.v. volume expansion, in patients at increased risk for CI-AKI. (1A)
  • 29.  We recommend not using oral fluids alone in patients at increased risk of CI-AKI. (1C)  We suggest using oral NAC, together with i.v. isotonic crystalloids, in patients at increased risk of CI-AKI. (2D)  Wesuggest not using theophylline to prevent CI- AKI. (2C)  Werecommend not using fenoldopam to prevent CI- AKI. (1B)  We suggest not using prophylactic intermittent hemodialysis (IHD) or hemofiltration (HF) for contrast-media removal in patients at increased risk for CI-AKI. (2C)
  • 30. The objective is to obtain a therapeutic drug concentration- time profile that is therapeutic and not toxic.
  • 31. GENERAL PRINCIPLES Be vigilant. Adverse renal effects of drugs are largely silent in the early stages . Identify patients at risk .Take precautions Manage the renal failure
  • 32. When in doubt about the cause of renal failure, hold all potentially offending drugs
  • 33. A careful history and physical examination are always the first steps in clinical evaluation of patients with renal disease. Particularly important for this purpose is the history of previous drug allergy or toxicity and the use of concurrent medications.
  • 34. Physical assessment should include An estimate of the extracellular fluid volume. Oh ?? Edema or ascites increases the distribution volume of many drugs, while dehydration contracts this volume. Evidence of impaired function of other excretory organs should be sought. Stigmata of liver disease are clue that the drug dose may need to be altered.
  • 35. II. Measurement of renal function the rate of elimination of drugs excreted by the kidneys is proportional to the glomerular filtration rate. The serum creatinine , creatinine clearance is needed to determine renal function before prescribing many drugs . The Cockcroft and Gault equation is useful for this purpose, as shown in the following formula: CrCl (ml/min)= (140-age)x (BW in kg)(x0.85if female) 72x Scr(mg/dl)
  • 36. The Scr reflects muscle mass as well as glomerular filtration rate. Scr measurement within the normal range are frequently used to establish normal renal function. This may cause serious over- dose and resultant toxic drugs accumulation in elderly or debilitated patients with decreased muscle mass.
  • 37. ?Do we have another option Cystatin –C is a good indicator of renal function specially in children and elderly patients Estimated GFR is the best way to assess progression of kidney disease in chronic renal patients
  • 38.
  • 39. Pretreatment hydration can reduce the nephrotoxic potential of many drugs. So ,it is very simple steps by which you can avoid getting yourself and your patient in a big problem.
  • 40.  What are special concerns regarding the use of antimicrobial agents in patients with renal failure?  The majority of antimicrobial agents are excreted at least partially by the kidney so that dose reductions often are apporpiate in patients with glumerular filtration rates less than 50% of normal. Gastrointestinal absorption of tetracycline and ciprofloxacin may me decreased if
  • 41. How should antibiotic doses be adjusted in patients with renal failure? Several antibiotics need dosage modification in the presence of renal failure, most cephalosporins, many penicillin's and vancomycin. The adjustments can be made by : 1. maintaining the usual dose and varying the dosing interval, 2. maintaining the dosing interval and varying the dose, 3. or a combination of the two.
  • 42. they are taken with phosphate-binding antacids. Decreased protein binding may contribute to increased neurotoxicity of betalactam antibiotics in patients with renal failure. Nephrotoxicity of antimicrobial agents is a major concern in patients with impaired renal function and limited renal reserve. The majority offenders are the aminoglycosides and Amophotercin.
  • 43. The catabolic effects of tetracycline may results in a rise in blood urea nitrogen and therefore its use should be avoided in patients with advanced renal insufficiency. Many of the penicillins are prepared with sodium or pottasium. High doses of such agents may be problematiac in renal patients with volume overload of hyperkalemia.
  • 44. Dosing of antimicrobial drugs in renal patients Antimicrobial and antiprotozoal drugs Drug Half-life Dosage for severe renal failure Normal/ESRD (h) Amoxycillin 0.09-2.3/5-20 Maximum 500 mgq 8h Amoxycillin Amoxycillin Maximum 375 mg q12 h Clavulanic acid PO 0.9-2.3/5-20 Clavulanic acid1/3-4 ampicillin 0.8-1.5/7-20 250-500 mg q6h Cefotaxime IV 1/15 1g loading dose then 50% standard dose
  • 45. Drug Half-life Dosage for severe renal failure Normal/ESRD (h) Ceftazidime IV 1.2/13-25 0.5-1 g q24h Ceftriaxone IV 7-9/12-24 1-2 g q24h Cefuroxime IV 1.2/17 750 mg q12h Cefuroxime PO 1.2/17 Standard dose Cephalexin 0.7/16 250-500 mg q12h Chloroquiine 7-14 days/5- 50 days Treatment:50% standard dose Ciprofloxacin IV/PO 3-6/6-9 50% standard dose q12h Calrithromycin 2.3-6.0/- 250 mg q12h Cotrimoxazole Sulphamethoxazole PCP treatment:Standard dose IV/PO 10/20-50 q48h Sulphamethoxazole/ Trimethoprime PCP prophylaxis Trimethoprime 9-13/20-49 25% Standard dose q48-72h Erythromycin IV/PO 1.4/5-6 50-75% Standard dose Max 1.5g in 24h
  • 46. Drug Half-life Dosage for severe renal failure Normal/ESRD (h) Flucloxacillin 0.8-1/3 Max PO 500 mg q6hIV 1g q 6 h Gentamicin IV 1.8/20-60 Titrate to levels Impenem/ cilastin IV Impenem ¼ 250 mg or 3.5 mg/kg q12 h Cilastin1/15-24 Meropenem IV 1.1/6-8 50% standard dose q24h Penoxymethyl-pencillin 0.6/4.1 Standard dose Piperacillin IV 0.8-1.8/3.3-5.1 4 g q12 h Piperacillin/dihydrochloride IV Piperacillin 0.18-0.3/3.3-5.1 4.5 g q12 h Dihydrochloride 1/7 Quinine difydrochloride IV 9 healthy,18 malaria/ Treat,emt 5-10 mg/kg q24h unchanged Trimethoprim 9-13/20-49 50% standard dose Vancomycin IV 6-8/200-250 Titrate to levels
  • 47. Dosing of common drugs in renal patients  Allopurinol-GFR 30 ml/min use 100mg,60ml/min use 200mg,90ml/min use 300mg  Corticosteroids-no need to change the dose  NSAIDs :-most are metabolized in the liver , aspirin is a good choice in renal impairment, - In ESRD patients ,no need for dose adjustment
  • 48.  In patients with low urine output avoid sulindac owing to renal stone formation.  Reduce dose of ketoprofen  Penicillamine ,avoid if GFR less than 50ml/min  Cyclosporine, no dose adjustment in renal insufficiency, however use of Cyclosporine can worsen renal insufficiency  Gold , if GFR 50-75ml/min use 50% of usual dose ,if less than 50% avoid gold
  • 49.  Methotrexate ,take care from hematologic toxicity  Tacrolimus (FK506,prograf)….Gout  Sulfasalasine ,no change in dose.  Mycophenylate mofetil (cellcept) ,mainly hepatic metabolism ,but if GFR less than 25 ml/min reduce dose by 25%.  Tramadol , give dose every 12 h instead of every 6h  Narcotics, avoid using Darvon and Mepiridine, for others if GFR less than 10ml/min cut 50% of the dose ,if GFR 10- 50ml/min use 75% of the dose
  • 50. You are what you repeatedly do; then excellence is not an art but just a habit Aristo
  • 51.
  • 52. nk y ou T ha